<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We recently found a markedly lower prevalence of vascular complications, including <z:e sem="disease" ids="C0022658" disease_type="Disease or Syndrome" abbrv="">kidney disease</z:e>, in diabetic patients with <z:e sem="disease" ids="C0017551" disease_type="Disease or Syndrome" abbrv="">Gilbert syndrome</z:e>, a congenital form of <z:hpo ids='HP_0002904'>hyperbilirubinemia</z:hpo>, suggesting a beneficial effect of <z:chebi fb="0" ids="16990">bilirubin</z:chebi> (BIL) on diabetic <z:hpo ids='HP_0000112'>nephropathy</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>To directly examine this, we determined whether hereditary hyperbilirubinemic Gunn j/j rats and <z:chebi fb="0" ids="17033">biliverdin</z:chebi> (BVD)-treated diabetic db/db mice were resistant to the development of <z:e sem="disease" ids="C0022658" disease_type="Disease or Syndrome" abbrv="">renal disease</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Both <z:e sem="disease" ids="C1519106" disease_type="Experimental Model of Disease" abbrv="">rodent models</z:e> had less <z:mp ids='MP_0002871'>albuminuria</z:mp> and complete protection against the progression of mesangial expansion accompanied by normalization of transforming growth factor-Î²1 and fibronectin expression </plain></SENT>
<SENT sid="3" pm="."><plain>Simultaneously, there was normalization of urinary and renal <z:mp ids='MP_0003674'>oxidative stress</z:mp> markers, and the expression of <z:chebi fb="0" ids="25523">nicotinamide adenine dinucleotide phosphate</z:chebi> (<z:chebi fb="0" ids="13392">NAD(P)H</z:chebi>) oxidase subunits in the kidney </plain></SENT>
<SENT sid="4" pm="."><plain>In cultured vascular endothelial and mesangial cells, BIL and BVD significantly inhibited <z:chebi fb="1" ids="16474">NADPH</z:chebi>-dependent <z:chebi fb="1" ids="18421">superoxide</z:chebi> production, and both high <z:chebi fb="105" ids="17234">glucose</z:chebi>- and <z:chebi fb="0" ids="2719,48432">angiotensin II</z:chebi>-induced production of reactive oxygen species </plain></SENT>
<SENT sid="5" pm="."><plain>Collectively, our findings suggest that BIL and BVD may protect against diabetic <z:hpo ids='HP_0000112'>nephropathy</z:hpo> and may lead to novel <z:chebi fb="11" ids="22586">antioxidant</z:chebi> therapies for diabetic <z:hpo ids='HP_0000112'>nephropathy</z:hpo> </plain></SENT>
</text></document>